Cited by 163Flavonoids in Medical ResearchTelomeres, Telomerase, and SenescencePhytochemicals and Antioxidant Activities

Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells

Open access
Perrott, Kevin M., Wiley, Christopher D., Desprez, Pierre-Yves, Campisi, Judith·2017·GeroScience

Abstract

Apigenin (4',5,7,-trihydroxyflavone) is a flavonoid found in certain herbs, fruits, and vegetables. Apigenin can attenuate inflammation, which is associated with many chronic diseases of aging. Senescent cells-stressed cells that accumulate with age in mammals-display a pro-inflammatory senescence-associated secretory phenotype (SASP) that can drive or exacerbate several age-related pathologies, including cancer. Flavonoids, including apigenin, were recently shown to reduce the SASP of a human fibroblast strain induced to senesce by bleomycin. Here, we confirm that apigenin suppresses the SASP in three human fibroblast strains induced to senesce by ionizing radiation, constitutive MAPK (mitogen-activated protein kinase) signaling, oncogenic RAS, or replicative exhaustion. Apigenin suppressed the SASP in part by suppressing IL-1α signaling through IRAK1 and IRAK4, p38-MAPK, and NF-κB. Apigenin was particularly potent at suppressing the expression and secretion of CXCL10 (IP10), a newly identified SASP factor. Further, apigenin-mediated suppression of the SASP substantially reduced the aggressive phenotype of human breast cancer cells, as determined by cell proliferation, extracellular matrix invasion, and epithelial-mesenchymal transition. Our results support the idea that apigenin is a promising natural product for reducing the impact of senescent cells on age-related diseases such as cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11357-017-9970-1

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Beside antioxidant activity, flavonoids have anti-inflammatory, vasodilator, anticoagulant, cardioprotective, anti-diabetic, neuroprotective, and anti-obesity activities, making them of interest as anti-aging compounds.

    “Beside the antioxidant activity, flavonoids have anti-inflammatory, vasodilator, anticoagulant, cardioprotective, anti-diabetic, neuroprotective, and anti-obesity activities, which make them of great interest as anti-aging compounds (Table 3) [228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Perrott, K. M., Wiley, C. D., Desprez, P.-Y., & Campisi, J.
Affiliations
  • Buck Institute for Research on Aging (US)
  • California Pacific Medical Center (US)
Corresponding author
Campisi, Judith
Venue
GeroScience
Published
2017-04
Volume
39
Issue
2
Pages
161-173
ISSN
  • 2152-4041 (ISSN-L)
  • 2509-2715
  • 2509-2723
OpenAlex
W2604407819
Cited by
163
References
42
Citations by year
2026: 8 · 2025: 21 · 2024: 28 · 2023: 18 · 2022: 17 · 2021: 19 · 2020: 22 · 2019: 15 · 2018: 10 · 2017: 5
FWCI
9.92
Type
journal article
Language
en
Open access
Locations
  • GeroScience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • SENS Research Foundation (BC2010)
  • National Institute on Aging (AG009909, AG017242)
Topics
  • Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
Keywords
apigenin, senescence-associated secretory phenotype, cellular senescence, flavonoids, breast cancer, IRAK1, IRAK4, p38 MAPK, NF-κB, CXCL10, paracrine effects, replicative senescence, oncogenic Ras, MAPK signaling, extracellular matrix invasion, epithelial-mesenchymal transition, inflammation, aging
MeSH terms
Breast Neoplasms, Female, Fibroblasts, Humans, Phenotype, Signal Transduction, Interleukin-6, NF-kappa B, Cellular Senescence, Cell Culture Techniques, Apigenin, p38 Mitogen-Activated Protein Kinases, Cell Proliferation, Interleukin-1alpha, Interleukin-1 Receptor-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review